DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 03 · Volume 116 · March 2008 DOI: 10.1055/s-002-12400

Article

143
Erdoğan, M.; Karadeniz, M.; Alper, G. E.; Tamsel, S.; Uluer, H.; Çağlayan, O.; Saygılı, F.; Yılmaz, C.: Thrombin-Activatable Fibrinolysis Inhibitor and Cardiovascular Risk Factors in Polycystic Ovary Syndrome
162
Seifarth, C. C.; Hinkmann, C.; Hahn, E.-G.; Lohmann, T.; Harsch, I. A.: Reduced Frequency of Peripheral Dendritic Cells in Type 2 Diabetes
167
Schwarz, P. E. H.; Lindström, J.; Kissimova-Scarbeck, K.; Szybinski, Z.; Barengo, N. C.; Peltonen, M.; Tuomilehto, J.; on behalf of the DE-PLAN project: The European Perspective of Type 2 Diabetes Prevention: Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) Project
173
178
184
Monami, M.; Lamanna, C.; Pala, L.; Bardini, G.; Cresci, B.; Francesconi, P.; Balzi, D.; Marchionni, N.; Rotella, C. M.; Mannucci, E.: Treatment with Insulin Secretagogues and Cancer-Related Mortality in Type 2 Diabetic Patients A Retrospective Cohort Study